Skip to main content
. 2017 Oct 16;8(56):96190–96202. doi: 10.18632/oncotarget.21878

Figure 1. The progression-free survival (PFS) and overall survival (OS) curves of esophageal squamous cell carcinoma patients with/without celiac LN metastasis.

Figure 1

(A) PFS, celiac LN metastasis group versus non-celiac metastasis LN group (B) PFS, celiac LN metastasis group versus matched non-celiac LN metastasis group using the propensity score matching method. (C) OS, celiac LN metastasis group versus non-celiac LN metastasis group (D) OS, celiac LN metastasis group versus matched non-celiac metastasis LN group using the propensity score matching method. LN: lymph node.